NASDAQ:PLSE Pulse Biosciences (PLSE) Stock Price, News & Analysis $17.11 -0.28 (-1.61%) (As of 11/14/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Pulse Biosciences Stock (NASDAQ:PLSE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pulse Biosciences alerts:Sign Up Key Stats Today's Range$16.84▼$17.6350-Day Range$14.56▼$20.3952-Week Range$5.80▼$22.69Volume133,762 shsAverage Volume203,855 shsMarket Capitalization$1.05 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Read More… Elon Musk has put himself in their crosshairs (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Pulse Biosciences Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks35th Percentile Overall ScorePLSE MarketRank™: Pulse Biosciences scored higher than 35% of companies evaluated by MarketBeat, and ranked 795th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Pulse Biosciences. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioPulse Biosciences has a P/B Ratio of 13.42. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pulse Biosciences' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted14.85% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 15.9, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently decreased by 7.64%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPulse Biosciences does not currently pay a dividend.Dividend GrowthPulse Biosciences does not have a long track record of dividend growth. Sustainability and ESG4.2 / 5Environmental Score-0.60 Percentage of Shares Shorted14.85% of the float of Pulse Biosciences has been sold short.Short Interest Ratio / Days to CoverPulse Biosciences has a short interest ratio ("days to cover") of 15.9, which indicates bearish sentiment.Change versus previous monthShort interest in Pulse Biosciences has recently decreased by 7.64%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment1.01 News SentimentPulse Biosciences has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for PLSE on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Pulse Biosciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pulse Biosciences insiders have not sold or bought any company stock.Percentage Held by Insiders71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pulse Biosciences' insider trading history. Receive PLSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address PLSE Stock News HeadlinesPulse Biosciences Inc PLSENovember 13 at 6:51 PM | morningstar.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024November 12 at 4:16 PM | investorplace.comElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.November 14, 2024 | Porter & Company (Ad)PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024November 11 at 11:17 AM | investorplace.comPulse Biosciences (NASDAQ:PLSE) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comPulse Biosciences Reports Q3 2024 Financials and DevelopmentsNovember 1, 2024 | markets.businessinsider.comPulse Biosciences Inc (6L8.MU)October 31, 2024 | ca.finance.yahoo.comPulse Biosciences Reports Positive Data From Benign Thyroid StudyOctober 31, 2024 | marketwatch.comSee More Headlines PLSE Stock Analysis - Frequently Asked Questions How have PLSE shares performed this year? Pulse Biosciences' stock was trading at $12.24 at the start of the year. Since then, PLSE shares have increased by 41.4% and is now trading at $17.31. View the best growth stocks for 2024 here. How were Pulse Biosciences' earnings last quarter? Pulse Biosciences, Inc. (NASDAQ:PLSE) issued its quarterly earnings data on Wednesday, October, 30th. The company reported ($0.21) earnings per share for the quarter. When did Pulse Biosciences IPO? Pulse Biosciences (PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO. Who are Pulse Biosciences' major shareholders? Pulse Biosciences' top institutional investors include Charles Schwab Investment Management Inc. (0.24%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (0.05%), Inspire Investing LLC (0.04%) and Creative Planning (0.04%). Insiders that own company stock include Mitchell E Levinson, Kevin Patrick Danahy and Burke Thomas Barrett. View institutional ownership trends. How do I buy shares of Pulse Biosciences? Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Pulse Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL). Company Calendar Last Earnings10/30/2024Today11/14/2024Fiscal Year End12/31/2024Next Earnings (Estimated)3/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PLSE CUSIPN/A CIK1625101 Webwww.pulsebiosciences.com Phone(510) 906-4600FaxN/AEmployees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-42,210,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-96.89% Return on Assets-74.83% Debt Debt-to-Equity RatioN/A Current Ratio11.93 Quick Ratio11.93 Sales & Book Value Annual Sales$700,000.00 Price / Sales1,510.76 Cash FlowN/A Price / Cash FlowN/A Book Value$1.29 per share Price / Book13.33Miscellaneous Outstanding Shares61,520,000Free Float17,532,000Market Cap$1.06 billion OptionableOptionable Beta1.75 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (NASDAQ:PLSE) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.